Report Details:
15 Companies Covered
200 Pages
Tissue Banking Market Highlights
The global tissue banking market Size was estimated at 4.528 USD Billion in 2024. The Tissue Banking industry is projected to grow from 4.769 USD Billion in 2025 to 8.0 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025 - 2035.
The single largest growth trend is the increasing prevalence of heart disease. The market space witnesses rising organ donation tendency across the globe which drives the growth of the tissue banking market. In addition, increasing the collaboration and partnership by the companies. One such key growth factor promoting an exponential increase in Year on Year (%) growth due to the rising awareness about the tissue banking is driving the growth of the tissue banking market.
Furthermore, incidence of cancer and diabetes propel the growth of tissue banking market. However, the lack of tissue banks in underdeveloped countries is expected to hamper the growth of the global market. Nevertheless, the rising advancement in drug discovery and development is projected to create lucrative opportunity pockets for market players. We estimate a more focused business initiates targeting the same would result in greater revenue pockets for market players.
Key Players
MRFR recognizes the following companies as the key players in the global tissue banking market Thermo Fisher Scientific Inc. (US), Sigma-Aldrich Co. (US), BioLifeSolutions (US). Thermo Fisher Scientific Inc. (US), Sigma-Aldrich Co. (US), BioLifeSolutions (US), Lifeline Scientific (US), BioCision, Cesca Therapeutics, Inc. (US),core dynamics GmbH (US), Custom Biogenic Systems (US),Atlanta Biologics Pvt. Ltd. (US), Taylor-Wharton (US), Panasonic Holdings Corporation (Japan), and among others.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Tissue Banking Market Research Report
Segment Analysis
The global tissue banking market is segmented into types, tissue type, and application. Based on the type of segment market is further sub segmented into media and consumable, cryopreservation equipment, thawing equipment, quality control equipment, others. The media and consumable segment were attributed to holding the largest market share in 2022 with a market share of 43.0% of revenue as estimated by MRFR analysts.
The launch of new products in the market. For instance, in May 2022, the major US report of selective fertility preservation outcomes to date found that 70% of women who froze eggs when they were youthful than 38 as well as defrosted at least 20 eggs at a future date.
Further, we estimate that the market segment will have an increasing tendency of organ donation, and rising prevalence of heart disease during the forecast period. It has been identified that the segment market yet witnesses continuous new product development and a growing number of product approvals. For instance, in June 2022, LifeLink Tissue Bank announced the launch of the Birth Tissue Donation Program, the first of its kind in the Tampa Bay area, in partnership with Tampa General Hospital (TGH).
Further, based on tissue type, the market is segmented into heart valve, cornea, bone, skin, brain & spinal cord, others. based on application channels are further sub segmented into therapeutics, medical research, others.
Regional Analysis
The global tissue banking market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World.
The tissue banking market for North America is analyzed across US and Canada. US accounted for a major share of the tissue banking market in 2022 and is expected to maintain its lead during the forecast period, due to the increasing tendency of egg frozen in the US, availability of advance technology, increasing healthcare infrastructure, developed economic condition boos the growth of tissue banking in the North America region.
Moreover, the Europe market has been persistently growing owing to factors such as the increasing technological development and product innovation, rising research and development activity, increasing occurrence of life threating disease such as heart disease, cancer, and others. Furthermore, increasing numbers of organ donors across the region is driving the growth of tissue banking. Furthermore, the Germany tissue banking market held the largest market share in 2022 and UK tissue banking market is the fastest growing market in the Europe region.
Additionally, market factors, such as an increasing investment by foreign companies, huge chronic disease population, increasing penetration of frozen eggs are driving the growth of tissue banking in the Asia-pacific region.
Furthermore, the rest of the world's market is divided into the Middle East, Africa, and Latin America. The market factors such as growing use of tissue banking, rising awareness about the organ donation for saving other life, growing new technological development and advance medical facility across the region are boost the growth of tissue banking in region.
Key Findings of the Study
- Technological advancements are reshaping the landscape of tissue banking, enhancing efficiency and safety.
- North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in tissue banking.
- The regenerative medicine segment dominates the market, whereas the tissue engineering segment is witnessing rapid growth.
- Key market drivers include technological innovations in tissue banking and rising applications in regenerative medicine.
